Denali Therapeutics shares owned by T. Rowe Price Investment Management
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by T. Rowe Price Investment Management
from 13F filings
Historical chart of T. Rowe Price Investment Management investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by T. Rowe Price Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $82M | 5.6M | 14.52 |
| 2025-06-30 | $45M | 3.2M | 13.99 |
| 2024-03-31 | $10M | 499k | 20.52 |
| 2023-09-30 | $13M | 647k | 20.63 |
| 2023-06-30 | $19M | 647k | 29.51 |
| 2023-03-31 | $15M | 647k | 23.04 |
| 2022-12-31 | $18M | 633k | 27.81 |
More positions owned by T. Rowe Price Investment Management
View all positions for T. Rowe Price Investment Management